177 related articles for article (PubMed ID: 23462279)
21. Project for the development of the linac based NCT facility in University of Tsukuba.
Kumada H; Matsumura A; Sakurai H; Sakae T; Yoshioka M; Kobayashi H; Matsumoto H; Kiyanagi Y; Shibata T; Nakashima H
Appl Radiat Isot; 2014 Jun; 88():211-5. PubMed ID: 24637084
[TBL] [Abstract][Full Text] [Related]
22. Optimization of the epithermal neutron beam for Boron Neutron Capture Therapy at the Brookhaven Medical Research Reactor.
Hu JP; Reciniello RN; Holden NE
Health Phys; 2004 May; 86(5 Suppl):S103-9. PubMed ID: 15069299
[TBL] [Abstract][Full Text] [Related]
23. Design of thermal neutron beam based on an electron linear accelerator for BNCT.
Zolfaghari M; Sedaghatizadeh M
Appl Radiat Isot; 2016 Dec; 118():149-153. PubMed ID: 27640175
[TBL] [Abstract][Full Text] [Related]
24. Critical review, with an optimistic outlook, on Boron Neutron Capture Therapy (BNCT).
Moss RL
Appl Radiat Isot; 2014 Jun; 88():2-11. PubMed ID: 24355301
[TBL] [Abstract][Full Text] [Related]
25. Be target development for the accelerator-based SPES-BNCT facility at INFN Legnaro.
Esposito J; Colautti P; Fabritsiev S; Gervash A; Giniyatulin R; Lomasov VN; Makhankov A; Mazul I; Pisent A; Pokrovsky A; Rumyantsev M; Tanchuk V; Tecchio L
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S270-3. PubMed ID: 19375334
[TBL] [Abstract][Full Text] [Related]
26. Overview of the IBA accelerator-based BNCT system.
Forton E; Stichelbaut F; Cambriani A; Kleeven W; Ahlback J; Jongen Y
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S262-5. PubMed ID: 19376728
[TBL] [Abstract][Full Text] [Related]
27. BNCT dose calculation in irregular fields using the sector integration method.
Blaumann HR; Sanz DE; Longhino JM; Larrieu OA
Appl Radiat Isot; 2004 Nov; 61(5):835-40. PubMed ID: 15308153
[TBL] [Abstract][Full Text] [Related]
28. The BSA modeling for the accelerator-based BNCT facility at INFN LNL for treating shallow skin melanoma.
Ceballos C; Esposito J
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S274-7. PubMed ID: 19376724
[TBL] [Abstract][Full Text] [Related]
29. Design and optimization of a beam shaping assembly for BNCT based on D-T neutron generator and dose evaluation using a simulated head phantom.
Rasouli FS; Masoudi SF
Appl Radiat Isot; 2012 Dec; 70(12):2755-62. PubMed ID: 23041781
[TBL] [Abstract][Full Text] [Related]
30. Characteristics of the new THOR epithermal neutron beam for BNCT.
Tung CJ; Wang YL; Hsu FY; Chang SL; Liu YW
Appl Radiat Isot; 2004 Nov; 61(5):861-4. PubMed ID: 15308158
[TBL] [Abstract][Full Text] [Related]
31. On accelerator-based neutron sources and neutron field characterization with low energy neutron spectrometer based on position sensitive 3He counter.
Murata I; Miyamaru H; Kato I; Mori Y
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S288-91. PubMed ID: 19376716
[TBL] [Abstract][Full Text] [Related]
32. [Development of BNCT based on research using accelerator based neutron source].
Kumada H
Igaku Butsuri; 2012; 32(3):104-10. PubMed ID: 24592679
[No Abstract] [Full Text] [Related]
33. Optimum design of a moderator system based on dose calculation for an accelerator driven Boron Neutron Capture Therapy.
Inoue R; Hiraga F; Kiyanagi Y
Appl Radiat Isot; 2014 Jun; 88():225-8. PubMed ID: 24440538
[TBL] [Abstract][Full Text] [Related]
34. Microdosimetry study of THOR BNCT beam using tissue equivalent proportional counter.
Hsu FY; Hsiao HW; Tung CJ; Liu HM; Chou FI
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S175-8. PubMed ID: 19447042
[TBL] [Abstract][Full Text] [Related]
35. Understanding the potentiality of accelerator based-boron neutron capture therapy for osteosarcoma: dosimetry assessment based on the reported clinical experience.
Bortolussi S; Postuma I; Protti N; Provenzano L; Ferrari C; Cansolino L; Dionigi P; Galasso O; Gasparini G; Altieri S; Miyatake SI; González SJ
Radiat Oncol; 2017 Aug; 12(1):130. PubMed ID: 28806981
[TBL] [Abstract][Full Text] [Related]
36. A dosimetric study on the use of bolus materials for treatment of superficial tumors with BNCT.
Seppälä T; Collan J; Auterinen I; Serén T; Salli E; Kotiluoto P; Kortesniemi M; Van Leemput K; Kankaanranta L; Joensuu H; Savolainen S
Appl Radiat Isot; 2004 Nov; 61(5):787-91. PubMed ID: 15308145
[TBL] [Abstract][Full Text] [Related]
37. Design of a beam shaping assembly and preliminary modelling of a treatment room for accelerator-based BNCT at CNEA.
Burlon AA; Girola S; Valda AA; Minsky DM; Kreiner AJ; Sánchez G
Appl Radiat Isot; 2011 Dec; 69(12):1688-91. PubMed ID: 21592806
[TBL] [Abstract][Full Text] [Related]
38. A TPD and AR based comparison of accelerator neutron irradiation fields between (7)Li and W targets for BNCT.
Tanaka K; Endo S; Yonai S; Baba M; Hoshi M
Appl Radiat Isot; 2014 Jun; 88():229-32. PubMed ID: 24359788
[TBL] [Abstract][Full Text] [Related]
39. Feasibility of boron neutron capture therapy (BNCT) for malignant pleural mesothelioma from a viewpoint of dose distribution analysis.
Suzuki M; Sakurai Y; Masunaga S; Kinashi Y; Nagata K; Maruhashi A; Ono K
Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1584-9. PubMed ID: 17056195
[TBL] [Abstract][Full Text] [Related]
40. Boron neutron capture therapy (BNCT) in Finland: technological and physical prospects after 20 years of experiences.
Savolainen S; Kortesniemi M; Timonen M; Reijonen V; Kuusela L; Uusi-Simola J; Salli E; Koivunoro H; Seppälä T; Lönnroth N; Välimäki P; Hyvönen H; Kotiluoto P; Serén T; Kuronen A; Heikkinen S; Kosunen A; Auterinen I
Phys Med; 2013 May; 29(3):233-48. PubMed ID: 22613369
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
